雲頂香港(00678.HK):猶他州銀行擬400萬美元出售龐巴迪飛機
格隆匯5月29日丨雲頂香港(00678.HK)公佈,於2021年6月29日,Crystal(公司的間接全資附屬公司,作為信託的唯一受益人)、賣方猶他州銀行與買方Resorts World Las Vegas LLC訂立有關買賣飛機的協議,總代價為400萬美元。飛機指由龐巴迪公司(Bombardier)於2007年製造的Global Express XRS飛機。
出售事項為集團持續出售非核心資產的一部分,此舉同時讓集團在2019新型冠狀病毒病引致的不確定因素影響下增強流動資金狀況。預期出售事項亦可節省維修及經營飛機的相關成本。出售事項的出售所得款項擬用作集團的一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.